Jiangsu Chinagreen Biological Technology Group Co.,Ltd. engages in the research, development, factory cultivation, and sale of edible fungi in China. It offers Flammulina velutipes; Pleurotus eryngii, including white jade mushroom and oyster mushroom; and Maitake mushrooms. The company was founded in 2010 and is headquartered in Suqian, China.
Frequently asked questions
What sector does Jiangsu Hualv Biological Technology Co.Ltd. (300970) operate in?
Jiangsu Hualv Biological Technology Co.Ltd. belongs to the Consumer Staples sector and operates in the Farm Products industry.
What is Jiangsu Hualv Biological Technology Co.Ltd. (300970) current stock price?
As of the latest data, Jiangsu Hualv Biological Technology Co.Ltd. stock price is CN¥17.29, with a previous close of CN¥17.62. Jiangsu Hualv Biological Technology Co.Ltd. lost -CN¥0.33 in the last trading session, representing a -1.87% loss.
What is Jiangsu Hualv Biological Technology Co.Ltd. (300970) current market capitalization?
Jiangsu Hualv Biological Technology Co.Ltd. market cap is approximately 2.74 billion.
What is Jiangsu Hualv Biological Technology Co.Ltd. (300970) Earnings Per Share (EPS)?
The trailing EPS is CN¥1.41.
What is Jiangsu Hualv Biological Technology Co.Ltd. (300970) Price-to-Earnings (P/E) ratio?
Jiangsu Hualv Biological Technology Co.Ltd. current P/E ratio is 12.26.
Does Jiangsu Hualv Biological Technology Co.Ltd. (300970) pay dividends?
Yes. Jiangsu Hualv Biological Technology Co.Ltd. pays annual dividends with an annualized yield of 2.89% and an estimated annual payout of CN¥0.50 per share.
When is the next ex-dividend date for Jiangsu Hualv Biological Technology Co.Ltd. (300970)?
The next ex-dividend date is scheduled for June 09, 2027.
What is Jiangsu Hualv Biological Technology Co.Ltd. (300970) beta (volatility) score?
Jiangsu Hualv Biological Technology Co.Ltd. has a beta of 0.880, meaning its volatility is roughly in line with the market.
